Moreover, the downregulation of AKT by siRNA could not inhibit BIM expression and phosphorylation induced by ATO, whereas the knockdown of BIM prevented AKT dephosphorylation in ovarian cancer cells. This evidence concerns the gene BCL2L11 and ovarian cancer.